Literature DB >> 12604980

Lactobacillus plantarum inhibits the intestinal epithelial migration of neutrophils induced by enteropathogenic Escherichia coli.

Sonia Michail1, Frank Abernathy.   

Abstract

BACKGROUND: Lactobacillus plantarum is a Gram-positive bacillus known for its effect as a probiotic agent. The goal of the study was to determine whether L. plantarum is capable of inhibiting the transepithelial neutrophil migration induced by enteropathogenic Escherichia coli (EPEC).
METHODS: Cultured intestinal epithelial T-84 cell monolayers were rapidly infected with EPEC. L. plantarum or culture supernatants were added to the monolayers before and after the infection. Indium-labeled neutrophils were added to the basolateral side of inverted monolayers. After 150-minute incubation, radioactivity of the neutrophils that migrated in the physiologic direction was assayed, and the number of migrating neutrophils was calculated. L. plantarum was also added to the monolayers before and after EPEC infection, and the number of adherent EPEC was determined by plate counting.
RESULTS: EPEC-induced neutrophil migration and EPEC binding to monolayers were inhibited by viable L. plantarum but only when added to the monolayers before EPEC. Culture supernatants failed to inhibit the neutrophil migration.
CONCLUSIONS: These results suggest that L. plantarum is beneficial in inhibiting neutrophil migration induced by EPEC, but only when preincubated with host epithelia. Rather than an indirect effect through a secreted substance produced by the probiotic agent, its effect is direct and requires the presence of the bacterium.

Entities:  

Mesh:

Year:  2003        PMID: 12604980     DOI: 10.1097/00005176-200303000-00017

Source DB:  PubMed          Journal:  J Pediatr Gastroenterol Nutr        ISSN: 0277-2116            Impact factor:   2.839


  7 in total

1.  Functional characterization and microencapsulation of probiotic bacteria from koozh.

Authors:  Shankar Ilango; Ruby Pandey; Usha Antony
Journal:  J Food Sci Technol       Date:  2016-01-15       Impact factor: 2.701

2.  Gut microbiota is not modified by Randomized, Double-blind, Placebo-controlled Trial of VSL#3 in Diarrhea-predominant Irritable Bowel Syndrome.

Authors:  Sonia Michail; Harshavardhan Kenche
Journal:  Probiotics Antimicrob Proteins       Date:  2011-03       Impact factor: 4.609

3.  Lactobacillus plantarum 299v Prevents Caspase-Dependent Apoptosis In Vitro.

Authors:  Natalie S Dykstra; Lucie Hyde; Alexander MacKenzie; David R Mack
Journal:  Probiotics Antimicrob Proteins       Date:  2011-03       Impact factor: 4.609

Review 4.  One Health Probiotics as Biocontrol Agents: One Health Tomato Probiotics.

Authors:  Natalya Harutyunyan; Almagul Kushugulova; Narine Hovhannisyan; Astghik Pepoyan
Journal:  Plants (Basel)       Date:  2022-05-18

Review 5.  Probiotics for the prevention of Hirschsprung-associated enterocolitis: a systematic review and meta-analysis.

Authors:  H Nakamura; T Lim; P Puri
Journal:  Pediatr Surg Int       Date:  2017-10-05       Impact factor: 1.827

6.  The host response to the probiotic Escherichia coli strain Nissle 1917: specific up-regulation of the proinflammatory chemokine MCP-1.

Authors:  Sya N Ukena; Astrid M Westendorf; Wiebke Hansen; Manfred Rohde; Robert Geffers; Sina Coldewey; Sebastian Suerbaum; Jan Buer; Florian Gunzer
Journal:  BMC Med Genet       Date:  2005-12-13       Impact factor: 2.103

7.  Bacillus clausii as adjunctive treatment for acute community-acquired diarrhea among Filipino children: a large-scale, multicenter, open-label study (CODDLE).

Authors:  Jo-Anne A de Castro; Mary Jean Villa-Real Guno; Marcos O Perez
Journal:  Trop Dis Travel Med Vaccines       Date:  2019-07-23
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.